Archives
-
(S)-Mephenytoin: CYP2C19 Assay Guide
2026-09-30
This scenario-driven guide explains how (S)-Mephenytoin, SKU C3414, can support controlled CYP2C19 and pharmacokinetic studies alongside cell viability or cytotoxicity workflows. It covers solvent selection, organoid compatibility, kinetic interpretation, storage, and practical vendor-selection criteria.
-
Pravastatin sodium Assay Workflows
2026-09-29
Pravastatin sodium adds a mechanistic HMG-CoA reductase inhibitor control to macrophage cholesterol, hepatocyte safety, and botanical-interaction assays. This guide connects cholesterol biosynthesis inhibition with transporter-aware workflows, practical dose planning, and troubleshooting decisions that separate target engagement from nonspecific cytotoxicity.
-
MSC–NRF2–ATF4 Signaling in Pancreatic Cancer
2026-09-29
This 2026 study shows that Se-methylselenocysteine elicits phenotype-dependent NRF2, ATF4, and ferroptosis-associated responses in pancreatic ductal adenocarcinoma cells. Its findings identify KYAT1-dependent metabolic activation, rather than compound exposure alone, as a key determinant of redox remodeling and suggest practical ways to distinguish adaptive stress signaling from iron-dependent cytotoxicity.
-
Danazol in HPG-Axis Research Workflows
2026-09-28
Danazol and Danocrine provide a practical perturbation tool for studying steroidogenesis, hypothalamic–pituitary–gonadal signaling, and endocrine phenotypes. This workflow translates a recent rat-model study into formulation guidance, assay design, troubleshooting, and comparative applications.
-
7-dehydro Cholesterol: From Sterol Flux to Immunity
2026-09-28
7-dehydro Cholesterol sits at the intersection of cholesterol biosynthesis, UVB-driven vitamin D3 formation, and oxidation-sensitive lipid biology. A 2026 grass carp study adds an important in vivo dimension: disrupting dhcr7 was associated with stronger antiviral responses and improved survival after GCRV-II challenge. This article considers what the findings establish, what remains uncertain, and how researchers can design rigorous sterol-perturbation studies without overextending cross-species conclusions.
-
DIDS Workflows for Tumor Stress and Ion Transport
2026-09-27
Use DIDS to probe anion transport and to design controlled studies of cell survival after near-lethal stress—two applications that require different controls and interpretations. This guide connects channel pharmacology with metastasis research while distinguishing published findings from practical starting conditions.
-
PP2A Links Autophagy to Candida Biofilm Drug Resistance
2026-09-26
The study links the PP2A catalytic subunit gene PPH21 to autophagy, biofilm formation, and antifungal resistance in Candida albicans. Its mutant and rapamycin experiments support a model in which PP2A-associated Atg13 phosphorylation helps activate Atg1, while the oral-infection mouse findings suggest that autophagy can reduce antifungal treatment efficacy in this setting.
-
(S)-Mephenytoin in Organoid PK Workflows
2026-09-25
Pair a defined CYP2C19 probe with human iPSC-derived intestinal models to ask whether a system supports measurable oxidative metabolism—not simply whether cells survive compound exposure. This practical guide separates established product and organoid findings from proposed assay conditions, with qualification steps for interpreting results.
-
PP2A Links Autophagy to Candida Biofilm Drug Resistance
2026-09-25
The study links the PP2A catalytic-subunit gene PPH21 to autophagy, biofilm formation, and antifungal response in Candida albicans. Its genetic, pharmacological, and mouse-model findings point to Atg13-associated regulation and Atg1 as candidate parts of this relationship, while leaving important questions about drug-specific effects and clinical transferability.
-
Açaí Extracts: Hepatocyte Toxicity and Induction
2026-09-24
This study compared açaí extracts from berry powder and commercial supplements using human hepatocytes and a complementary transporter assay. Some extracts reduced hepatocyte viability in a dose- and time-dependent manner, but the study found no significant induction of the tested CYP enzymes or transporters, emphasizing the need to separate cytotoxicity from interaction potential.
-
HPF (Hydroxyphenyl Fluorescein): Specificity and Use
2026-09-24
HPF (hydroxyphenyl fluorescein) is an oxidation-activated fluorescent probe for detecting highly reactive oxygen species, including hydroxyl radicals and peroxynitrite. Its selectivity profile makes it useful for intracellular oxidative stress visualization, but its fluorescence is not a direct measure of total ROS or a substitute for independent mechanistic validation.
-
Danazol Workflows for Endocrine Model Research
2026-09-23
Use Danazol to probe steroidogenesis and hypothalamic–pituitary–gonadal signaling, with a practical workflow that connects cell-based assays to developmental models. A recent rat study highlights how Danazol-induced puberty models can test interventions while underscoring the need to separate measured endpoints from inferred mechanisms.
-
Sulfaphenazole: CYP2C9 Inhibitor Workflows
2026-09-23
Sulfaphenazole supports two complementary research paths: controlled CYP2C9 inhibition for drug metabolism and vascular assays, plus in vitro antibacterial testing. This guide translates published vascular findings into executable workflows, controls, troubleshooting decisions, and cross-domain study designs.
-
Tetracycline Workflows for Reliable Ribosome Research
2026-09-22
Tetracycline combines reversible ribosomal targeting with practical value as an antibiotic selection marker and microbiological research tool. This workflow-focused guide shows how to build reproducible bacterial assays while responsibly separating those applications from LKB1–telomerase findings in lung adenocarcinoma.
-
Pravastatin Sodium in Transporter-Aware Assays
2026-09-22
Pravastatin sodium is a selective HMG-CoA reductase inhibitor whose assay behavior depends on both target engagement and cellular transport. This guide connects cholesterol biosynthesis inhibition with hepatocyte viability, OATP biology, and botanical-drug interaction screening for more interpretable translational experiments.